ZD1839 (Iressa): an orally active inhibitor of epidermal growth factor signaling with potential for cancer therapy. (Q44183110)
Jump to navigation
Jump to search
scientific article published in October 2002
Language | Label | Description | Also known as |
---|---|---|---|
English | ZD1839 (Iressa): an orally active inhibitor of epidermal growth factor signaling with potential for cancer therapy. |
scientific article published in October 2002 |
Statements
ZD1839 (Iressa): an orally active inhibitor of epidermal growth factor signaling with potential for cancer therapy (English)
Alan E Wakeling
Simon P Guy
Jim R Woodburn
Susan E Ashton
Brenda J Curry
Andrew J Barker